Depression
Recent findings from M. Taler and co-authors highlight research in depression
Published in Drug Law Weekly, March 4th, 2008
"Therefore, we evaluated the ex-vivo immunomodulatory effect of selective serotonin reuptake inhibitors (SSRIs) in TceLLs. We found that the SSRIs, paroxetine and sertraline decreased T-cell viability with IC50 around 10 mc M. The inhibition obtained with exposure to the SSRIs was more pronounced than that achieved with dexamethasone. Moreover, these SSRIs inhibit the secretion of the TH1 factor-tumor necrosis factor(TNF)alpha...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
Source: Drug Law Weekly (2008-03-04)
More Articles from Drug Law Weekly
- Anapol, Schwartz, Weiss, Cohan, Feldman & Smalley
Anapol Schwartz Attorney Representing Trasylol(R) Victims Says Medical Study - Confirming Heart Bypass Drug Mortality Risk - to Open Floodgates for More Litigation - Biopharmaceuticals
Genmab Agrees to Buy Minnesota Biotech Manufacturing Plant from PDL Biopharma - Biopharmaceuticals
Genmab and PDL BioPharma Sign Purchase Agreement for Antibody Manufacturing Facility - Cancer
Acceleron Pharma Announces Global Collaboration with Celgene Corporation on ACE-011 Program for Cancer-Related Bone Loss - CSL Behring
CSL Behring Launches LEAD Program to Support Patient Group Advocacy Efforts - Dental Hygienist
MNDHA Supports Advanced Dental Hygiene Practitioner Bill in Legislature of the State of Minnesota - More from this issue of Drug Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
